Cargando…

Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond

Recent clinical trials have now firmly established that inflammation participates causally in human atherosclerosis. These observations point the way toward novel treatments that add to established therapies to help stem the growing global epidemic of cardiovascular disease. Fortunately, we now have...

Descripción completa

Detalles Bibliográficos
Autor principal:	Libby, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073599/ https://www.ncbi.nlm.nih.gov/pubmed/33924019 http://dx.doi.org/10.3390/cells10040951

Ejemplares similares

Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
por: Tanaka, Toshio, et al.
Publicado: (2012)

Inflammasome signaling and regulation of interleukin-1 family cytokines
por: Chan, Amy H., et al.
Publicado: (2019)

Complexity of Inflammation in the Trajectory of Vascular Disease: Interleukin 6 and Beyond
por: Sano, Motoaki
Publicado: (2023)

Interleukin-6 and rheumatic diseases
por: Lipsky, Peter E
Publicado: (2006)

Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
por: Vecchié, Alessandra, et al.
Publicado: (2021)

Interleukin-6 inhibition in the management of non-infectious uveitis and beyond
por: Karkhur, Samendra, et al.
Publicado: (2019)

Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir
por: HIRANO, Toshio
Publicado: (2010)

Targeting interleukin-6 for noninfectious uveitis
por: Lin, Phoebe
Publicado: (2015)

Effect of interleukin-31 on septic shock through regulating inflammasomes and interleukin-1β
por: Gu, Xuyun, et al.
Publicado: (2018)

Role of interleukin‐15 in cardiovascular diseases
por: Guo, Lei, et al.
Publicado: (2020)

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
por: Makris, Anastasios, et al.
Publicado: (2023)

Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation
por: Kalliolias, George D, et al.
Publicado: (2009)

Progress of Research into the Interleukin-1 Family in Cardiovascular Disease
por: Wu, Zimin, et al.
Publicado: (2022)

Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
por: Waldmann, Thomas A
Publicado: (2004)

Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2023)

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis
por: Wang, Runsheng, et al.
Publicado: (2021)

Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures
por: Sun, Yi, et al.
Publicado: (2019)

The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis
por: Davies, Ruth, et al.
Publicado: (2020)

Interleukin-6: a new therapeutic target
por: Smolen, Josef S, et al.
Publicado: (2006)

The Role of Interleukin-6 Family Members in Cardiovascular Diseases
por: Feng, Yongqi, et al.
Publicado: (2022)

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
por: Potere, Nicola, et al.
Publicado: (2022)

The emerging role of interleukin‐37 in cardiovascular diseases
por: Zhuang, Xinyu, et al.
Publicado: (2017)

Interleukin-6 signalling in health and disease
por: Rose-John, Stefan
Publicado: (2020)

Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective
por: Zwicky, Pascale, et al.
Publicado: (2019)

Interleukin-32 in Inflammatory Autoimmune Diseases
por: Kim, Soohyun
Publicado: (2014)

Interleukin-17 in human inflammatory diseases
por: Shabgah, Arezoo Gowhari, et al.
Publicado: (2014)

Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction
por: Greenhill, Claire J, et al.
Publicado: (2014)

A roadmap to target interleukin-6 in osteoarthritis
por: Wiegertjes, Renske, et al.
Publicado: (2020)

Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence
por: Dimosiari, Athina, et al.
Publicado: (2023)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Simultaneous targeting of interleukin-1 and interleukin-18 is required for protection against inflammatory and septic shock
por: Berghe, T Vanden, et al.
Publicado: (2014)

Targeting the Inflammasome in Cardiovascular Disease
por: Olsen, Maria Belland, et al.
Publicado: (2021)

Interleukins in cancer: from biology to therapy
por: Briukhovetska, Daria, et al.
Publicado: (2021)

Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity
por: Jiang, Xintong, et al.
Publicado: (2019)

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
por: Wang, Yucheng, et al.
Publicado: (2020)

Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson
por: Krawiec, Paulina, et al.
Publicado: (2021)

Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond
por: Sugiura, Kazumitsu
Publicado: (2022)

Interleukin-6 and chronic inflammation
por: Gabay, Cem
Publicado: (2006)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qvll99bk1cahsg2083v711tsk0